Ceritinib D7 is a deuterium-labeled active pharmaceutical ingredient used in research and pharmaceutical manufacturing. It is a chemical compound with a complex structure containing amine, ether, and halogen functional groups, designed for analytical and developmental studies.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1632484-77-5
Sitafloxacin
active pharmaceutical ingredient
((plusmn))-Zanubrutinib
active pharmaceutical ingredient
(3R,4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
active pharmaceutical ingredient
Teriflunomide
active pharmaceutical ingredient
Ceritinib
active pharmaceutical ingredient
5-chloro-2-N-[2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yloxy)-5-methyl-4-piperidin-4-ylphenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
VERWOWGGCGHDQE-WFBMWZOZSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])OC1=C(C=C(C(=C1)C2CCNCC2)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl